Programs
· 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door · 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door
Disclaimer: These compounds are considered investigational and have not been evaluated or approved by the U.S. FDA. They are used for research purposes under direct clinical supervision. These treatments are not intended to diagnose, treat, or cure injuries or chronic inflammatory conditions. Use is subject to provider discretion and rigorous medical monitoring.

BPC-157/KPV

Investigational peptide combination that may support gut barrier function and inflammatory balance pathways within clinician-guided regenerative protocols.

How It Feels

  • A noticeable sense of digestive calm and reduced post-meal discomfort over time
  • Less bloating and a lighter, more comfortable feeling after eating
  • Improved tolerance to a wider range of foods during structured use
  • A calmer, more balanced internal “baseline” day to day

Four Rules for Success

  • Use only within a clinician-designed investigational protocol
  • Stay consistent – gut and inflammatory pathways respond over time
  • Do not stack with additional peptides unless clinically guided
  • Support outcomes with stable nutrition and routine adherence
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES

The Science Behind BPC-157 + KPV

BPC-157 is a synthetic peptide studied for its role in tissue repair signaling and gastrointestinal mucosal integrity pathways. KPV is a tripeptide fragment of alpha-MSH studied for its role in inflammatory signaling modulation and microbial balance pathways. Together, they are used in investigational settings targeting gut barrier and inflammatory response systems.

Usage & Dosage

  • Oral administration
  • Typically used daily within structured cycles
  • Best taken on an empty stomach for gut exposure
  • Duration and dosing must be clinician-determined
  • Response varies based on baseline gut and inflammatory status

 

Disclaimer: These compounds are considered investigational and have not been evaluated or approved by the U.S. FDA. They are used for research purposes under direct clinical supervision. These treatments are not intended to diagnose, treat, or cure injuries or chronic inflammatory conditions. Use is subject to provider discretion and rigorous medical monitoring.